A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.
Key Details
- 1Systematic review covers research from 2006–2025 on AI in breast cancer imaging.
- 2AI-assisted mammography detects 29% more cancers compared to conventional reading without increasing false positives.
- 3AI reduces mammography reading time by ~40%, increasing radiologist efficiency.
- 4AI in 3D digital breast tomosynthesis finds 1.6 more cancers per 1,000 screens and reduces recall rate by 2.2%.
- 5AI in MRI identified imaging features up to one year pre-diagnosis and localized future cancer in 57% of cases.
- 6AI models also improve ultrasound interpretation consistency and biopsy analysis for recurrence risk.
Why It Matters
The review synthesizes evidence showing that AI not only boosts diagnostic accuracy and efficiency across imaging modalities, but also supports risk prediction and precision medicine. This highlights the growing value of AI as a clinical decision-support tool in breast imaging and underscores the challenges ahead for broad, equitable clinical adoption.
Source
EurekAlert
Related News
•EurekAlert
New G-AUDIT Tool Detects Hidden Bias in Medical AI Training Data
Johns Hopkins and FDA researchers unveil G-AUDIT, a tool to identify hidden biases in medical AI datasets before model training.
•EurekAlert
AI-Driven Bone Marrow Mapping Tool Improves Blood Cancer Assessment
Weill Cornell Medicine develops an AI tool to score and track disease severity in blood cancer from bone marrow imaging.
•EurekAlert
Bio-Inspired E-Skin Achieves High-Fidelity Signal Capture and ML-Controlled Teleoperation
Researchers develop a breathing, stretchable e-skin for robust biosignal acquisition and AI-driven teleoperation, outperforming conventional electrodes.